Yea Christopher bought KALV
May 27, 2026 · Form 4 insider transaction
Yea Christopher bought 33,800 shares of KalVista Pharmaceuticals Inc at $7.07 per share, a transaction worth $239.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,800
Price
$7.07
Total value
$239.0K
InsiderYea Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after263,718
OwnershipDirect
10b5-1 planNo
AmendedNo